NCT05479097Completed
Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage
A Feasibility Study of a Novel mHealth Clinical Decision Support Application to Enable Community Health Workers to Manage Hypertension With Remote Physician Supervision
Source: ClinicalTrials.gov · Last updated 16 Jul 2024
Brief summary (registry, in English)
This is a single group study assessing the feasibility of hypertension management by community health workers (CHWs) equipped with a mobile clinical decision support (CDS) application and working with remote physician supervision.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 26 Jul 2022
- Start date
- 6 Feb 2023
- Primary completion date
- 15 Aug 2023
- Lead sponsor
- University of Wisconsin, Madison
- Diseases
- High blood pressure
- NCT number
- NCT05479097
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 6 Feb 2023 to the primary completion date, 15 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe comorbid condition(s) with life expectancy less than 1 year
Other
- Pregnancy
Who the study is looking for
- Greater than 18 years old
- Diagnosed with hypertension
- Blood pressure greater than or equal to 140/90 mm Hg OR
- currently taking antihypertensive medication
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| San Lucas Mission Coordinator of this site? Confirm its status | San Lucas Tolimán | Guatemala | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.